Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Oropharyngeal Neoplasms | 30 | 2023 | 477 | 8.420 |
Why?
|
Head and Neck Neoplasms | 58 | 2023 | 2732 | 6.250 |
Why?
|
Free Tissue Flaps | 15 | 2024 | 328 | 4.030 |
Why?
|
Laryngectomy | 13 | 2023 | 248 | 3.660 |
Why?
|
Carcinoma, Squamous Cell | 38 | 2023 | 4033 | 3.630 |
Why?
|
Thyroidectomy | 12 | 2020 | 879 | 2.930 |
Why?
|
Papillomavirus Infections | 20 | 2023 | 1587 | 2.850 |
Why?
|
Neck | 14 | 2021 | 696 | 2.680 |
Why?
|
Robotics | 14 | 2017 | 899 | 2.630 |
Why?
|
Surgical Flaps | 15 | 2021 | 1640 | 2.620 |
Why?
|
Neck Dissection | 11 | 2023 | 197 | 2.540 |
Why?
|
Natural Orifice Endoscopic Surgery | 8 | 2021 | 118 | 2.420 |
Why?
|
Pharyngeal Diseases | 4 | 2019 | 133 | 1.880 |
Why?
|
Otorhinolaryngologic Surgical Procedures | 7 | 2021 | 312 | 1.820 |
Why?
|
Tongue Neoplasms | 7 | 2023 | 180 | 1.760 |
Why?
|
Parotid Neoplasms | 4 | 2021 | 155 | 1.750 |
Why?
|
Otolaryngology | 6 | 2018 | 645 | 1.720 |
Why?
|
Papillomaviridae | 13 | 2023 | 1119 | 1.650 |
Why?
|
Microsurgery | 5 | 2018 | 796 | 1.560 |
Why?
|
Deglutition Disorders | 7 | 2023 | 605 | 1.550 |
Why?
|
Mouth | 10 | 2021 | 374 | 1.480 |
Why?
|
Pharyngectomy | 4 | 2016 | 45 | 1.430 |
Why?
|
Head | 7 | 2022 | 880 | 1.360 |
Why?
|
Endoscopy | 7 | 2021 | 1784 | 1.300 |
Why?
|
Laryngeal Neoplasms | 6 | 2017 | 512 | 1.130 |
Why?
|
Postoperative Complications | 27 | 2024 | 15294 | 1.120 |
Why?
|
Surgery, Oral | 3 | 2014 | 146 | 1.110 |
Why?
|
Alphapapillomavirus | 6 | 2022 | 221 | 1.110 |
Why?
|
Paranasal Sinus Neoplasms | 4 | 2023 | 234 | 1.020 |
Why?
|
Oral Surgical Procedures | 4 | 2021 | 168 | 0.930 |
Why?
|
Cutaneous Fistula | 2 | 2013 | 78 | 0.860 |
Why?
|
Parathyroidectomy | 2 | 2020 | 235 | 0.790 |
Why?
|
Pharynx | 2 | 2014 | 413 | 0.780 |
Why?
|
Rhytidoplasty | 1 | 2021 | 60 | 0.750 |
Why?
|
Nasal Septum | 3 | 2006 | 127 | 0.740 |
Why?
|
Airway Obstruction | 2 | 2018 | 663 | 0.740 |
Why?
|
Nose Neoplasms | 2 | 2021 | 246 | 0.710 |
Why?
|
Sialometaplasia, Necrotizing | 1 | 2019 | 6 | 0.700 |
Why?
|
Education | 2 | 2013 | 543 | 0.690 |
Why?
|
Computer-Assisted Instruction | 2 | 2013 | 365 | 0.690 |
Why?
|
Larynx, Artificial | 3 | 2017 | 69 | 0.680 |
Why?
|
Mouth Neoplasms | 6 | 2023 | 601 | 0.660 |
Why?
|
Speech Disorders | 2 | 2021 | 189 | 0.660 |
Why?
|
Parathyroid Glands | 2 | 2018 | 509 | 0.660 |
Why?
|
Anastomosis, Surgical | 3 | 2017 | 987 | 0.650 |
Why?
|
Leeching | 1 | 2018 | 6 | 0.640 |
Why?
|
Vascular Surgical Procedures | 3 | 2018 | 1475 | 0.640 |
Why?
|
Deglutition | 3 | 2022 | 197 | 0.640 |
Why?
|
Nose Deformities, Acquired | 1 | 2018 | 44 | 0.630 |
Why?
|
Patient Care Planning | 2 | 2021 | 921 | 0.630 |
Why?
|
Humans | 157 | 2024 | 744220 | 0.630 |
Why?
|
Glossectomy | 3 | 2023 | 58 | 0.620 |
Why?
|
Tracheostomy | 4 | 2023 | 400 | 0.620 |
Why?
|
Surgery, Computer-Assisted | 3 | 2014 | 1018 | 0.610 |
Why?
|
Tongue | 8 | 2023 | 406 | 0.610 |
Why?
|
Comprehension | 1 | 2023 | 610 | 0.600 |
Why?
|
Arteries | 4 | 2022 | 1119 | 0.590 |
Why?
|
Radiation Oncology | 1 | 2023 | 555 | 0.580 |
Why?
|
Thyroid Diseases | 2 | 2017 | 378 | 0.580 |
Why?
|
Scapula | 1 | 2018 | 164 | 0.580 |
Why?
|
Hyperemia | 1 | 2018 | 225 | 0.570 |
Why?
|
Pharyngeal Neoplasms | 2 | 2014 | 117 | 0.560 |
Why?
|
Fibrin Tissue Adhesive | 2 | 2007 | 85 | 0.550 |
Why?
|
Postoperative Care | 3 | 2017 | 1485 | 0.550 |
Why?
|
Retrospective Studies | 47 | 2024 | 77426 | 0.540 |
Why?
|
Skin Transplantation | 2 | 2018 | 1074 | 0.510 |
Why?
|
Antithrombins | 1 | 2018 | 304 | 0.510 |
Why?
|
Pain, Postoperative | 2 | 2020 | 1640 | 0.500 |
Why?
|
Salvage Therapy | 7 | 2018 | 1275 | 0.500 |
Why?
|
Jugular Veins | 1 | 2015 | 204 | 0.490 |
Why?
|
Hypopharynx | 2 | 2019 | 52 | 0.480 |
Why?
|
Fibula | 3 | 2024 | 269 | 0.460 |
Why?
|
Palatine Tonsil | 1 | 2014 | 193 | 0.460 |
Why?
|
Middle Aged | 68 | 2024 | 213367 | 0.460 |
Why?
|
Endoscopes | 1 | 2014 | 175 | 0.460 |
Why?
|
Laser Therapy | 2 | 2012 | 1072 | 0.440 |
Why?
|
Graft Survival | 5 | 2018 | 3740 | 0.420 |
Why?
|
Cadaver | 6 | 2019 | 1337 | 0.420 |
Why?
|
Nasopharyngeal Neoplasms | 3 | 2023 | 286 | 0.420 |
Why?
|
Parotid Gland | 3 | 2023 | 168 | 0.420 |
Why?
|
Tonsillectomy | 3 | 2016 | 254 | 0.410 |
Why?
|
Nasopharynx | 1 | 2014 | 379 | 0.410 |
Why?
|
Male | 83 | 2024 | 350027 | 0.400 |
Why?
|
Tumor Virus Infections | 1 | 2014 | 452 | 0.400 |
Why?
|
Tonsillar Neoplasms | 1 | 2011 | 51 | 0.400 |
Why?
|
Skull Base | 1 | 2014 | 306 | 0.390 |
Why?
|
Human papillomavirus 16 | 4 | 2017 | 262 | 0.390 |
Why?
|
Salivary Glands | 1 | 2012 | 229 | 0.380 |
Why?
|
Carcinoma | 4 | 2016 | 2375 | 0.370 |
Why?
|
Chorionic Gonadotropin, beta Subunit, Human | 1 | 2010 | 73 | 0.370 |
Why?
|
Internship and Residency | 4 | 2018 | 5787 | 0.370 |
Why?
|
Aged | 48 | 2023 | 163253 | 0.370 |
Why?
|
Feasibility Studies | 6 | 2020 | 5076 | 0.360 |
Why?
|
Intubation, Intratracheal | 1 | 2018 | 1357 | 0.360 |
Why?
|
Female | 76 | 2024 | 380197 | 0.360 |
Why?
|
Temporal Bone | 1 | 2014 | 661 | 0.360 |
Why?
|
Tracheal Stenosis | 1 | 2012 | 226 | 0.350 |
Why?
|
Monitoring, Physiologic | 1 | 2017 | 1737 | 0.350 |
Why?
|
Neoplasm Recurrence, Local | 10 | 2021 | 9230 | 0.350 |
Why?
|
Equipment Failure | 1 | 2012 | 579 | 0.340 |
Why?
|
Thyroid Neoplasms | 3 | 2017 | 2281 | 0.340 |
Why?
|
Laryngoscopy | 3 | 2011 | 706 | 0.340 |
Why?
|
Neoplasm Staging | 17 | 2023 | 11007 | 0.340 |
Why?
|
Length of Stay | 10 | 2021 | 6308 | 0.330 |
Why?
|
Epistaxis | 2 | 2007 | 111 | 0.330 |
Why?
|
DNA, Viral | 8 | 2023 | 2226 | 0.330 |
Why?
|
Tongue Diseases | 1 | 2009 | 67 | 0.330 |
Why?
|
Combined Modality Therapy | 9 | 2021 | 8628 | 0.320 |
Why?
|
Clinical Competence | 5 | 2018 | 4687 | 0.320 |
Why?
|
Rhabdomyosarcoma | 1 | 2011 | 382 | 0.320 |
Why?
|
Education, Medical, Undergraduate | 1 | 2017 | 1007 | 0.320 |
Why?
|
Device Removal | 2 | 2017 | 656 | 0.310 |
Why?
|
Ehlers-Danlos Syndrome | 1 | 2009 | 89 | 0.310 |
Why?
|
Hospital Costs | 1 | 2014 | 984 | 0.310 |
Why?
|
Enteral Nutrition | 2 | 2016 | 763 | 0.300 |
Why?
|
Epiglottis | 2 | 2017 | 79 | 0.300 |
Why?
|
Surgical Wound Infection | 4 | 2022 | 1540 | 0.280 |
Why?
|
Cicatrix | 2 | 2023 | 764 | 0.280 |
Why?
|
Dysphonia | 1 | 2009 | 144 | 0.280 |
Why?
|
Cone-Beam Computed Tomography | 3 | 2015 | 450 | 0.280 |
Why?
|
Adult | 42 | 2021 | 214035 | 0.270 |
Why?
|
Curriculum | 2 | 2016 | 3604 | 0.260 |
Why?
|
Peptide Fragments | 1 | 2018 | 5096 | 0.260 |
Why?
|
Telangiectasia, Hereditary Hemorrhagic | 1 | 2007 | 139 | 0.260 |
Why?
|
Laparoscopy | 1 | 2017 | 2149 | 0.250 |
Why?
|
Radiotherapy, Intensity-Modulated | 3 | 2016 | 806 | 0.240 |
Why?
|
Analgesics, Opioid | 1 | 2020 | 3674 | 0.240 |
Why?
|
Lymphatic Metastasis | 3 | 2022 | 2914 | 0.240 |
Why?
|
Hemostatics | 1 | 2007 | 229 | 0.240 |
Why?
|
Treatment Outcome | 19 | 2023 | 63119 | 0.240 |
Why?
|
Facial Nerve Diseases | 1 | 2004 | 50 | 0.230 |
Why?
|
Aged, 80 and over | 19 | 2022 | 57768 | 0.230 |
Why?
|
Thyroid Gland | 4 | 2018 | 1172 | 0.230 |
Why?
|
Prospective Studies | 16 | 2021 | 53280 | 0.220 |
Why?
|
Risk Assessment | 10 | 2021 | 23337 | 0.220 |
Why?
|
Growth Substances | 1 | 2005 | 783 | 0.220 |
Why?
|
Cranial Nerve Neoplasms | 1 | 2004 | 129 | 0.220 |
Why?
|
Patient Discharge | 2 | 2021 | 3313 | 0.220 |
Why?
|
Mandible | 4 | 2016 | 740 | 0.220 |
Why?
|
Esophageal Stenosis | 1 | 2023 | 195 | 0.210 |
Why?
|
Nasal Cavity | 2 | 2021 | 313 | 0.200 |
Why?
|
Cartilage | 1 | 2005 | 818 | 0.200 |
Why?
|
Cross-Sectional Studies | 7 | 2022 | 25043 | 0.200 |
Why?
|
Quality of Life | 7 | 2023 | 12805 | 0.200 |
Why?
|
Weight-Bearing | 1 | 2024 | 515 | 0.200 |
Why?
|
Joint Instability | 1 | 2009 | 792 | 0.200 |
Why?
|
Sleep Apnea, Obstructive | 1 | 2014 | 1812 | 0.190 |
Why?
|
Fistula | 2 | 2013 | 220 | 0.190 |
Why?
|
Speech | 2 | 2023 | 540 | 0.190 |
Why?
|
Academic Medical Centers | 1 | 2011 | 2759 | 0.190 |
Why?
|
Cause of Death | 1 | 2011 | 3584 | 0.190 |
Why?
|
Prognosis | 16 | 2021 | 29050 | 0.190 |
Why?
|
Blood-Brain Barrier | 2 | 1998 | 1016 | 0.180 |
Why?
|
Hospital Mortality | 1 | 2014 | 5316 | 0.180 |
Why?
|
Radiotherapy, Adjuvant | 3 | 2020 | 1770 | 0.180 |
Why?
|
Heme Oxygenase (Decyclizing) | 2 | 1998 | 171 | 0.180 |
Why?
|
Chondrocytes | 1 | 2005 | 803 | 0.180 |
Why?
|
Cervical Plexus | 1 | 2019 | 12 | 0.180 |
Why?
|
Antibiotic Prophylaxis | 3 | 2022 | 638 | 0.180 |
Why?
|
Neoplasms, Multiple Primary | 1 | 2004 | 601 | 0.180 |
Why?
|
Orthognathic Surgical Procedures | 1 | 2021 | 115 | 0.180 |
Why?
|
Disease-Free Survival | 6 | 2017 | 6893 | 0.170 |
Why?
|
Societies, Medical | 3 | 2021 | 3741 | 0.170 |
Why?
|
Gastrostomy | 3 | 2017 | 309 | 0.170 |
Why?
|
Cartilage, Articular | 1 | 2006 | 1095 | 0.170 |
Why?
|
Models, Biological | 1 | 2015 | 9582 | 0.170 |
Why?
|
Dissection | 2 | 2019 | 295 | 0.170 |
Why?
|
Databases as Topic | 1 | 2021 | 475 | 0.170 |
Why?
|
Anti-Infective Agents, Local | 1 | 2021 | 250 | 0.160 |
Why?
|
Maxilla | 1 | 2021 | 470 | 0.160 |
Why?
|
United States | 14 | 2022 | 69867 | 0.160 |
Why?
|
Maryland | 2 | 2016 | 276 | 0.160 |
Why?
|
Neurilemmoma | 1 | 2004 | 547 | 0.160 |
Why?
|
Neoplasm Invasiveness | 6 | 2023 | 3614 | 0.160 |
Why?
|
Nasal Mucosa | 1 | 2021 | 373 | 0.160 |
Why?
|
Nose | 2 | 2019 | 509 | 0.160 |
Why?
|
Palate | 1 | 2018 | 123 | 0.160 |
Why?
|
Lymph Nodes | 4 | 2017 | 3469 | 0.150 |
Why?
|
Extracellular Matrix | 1 | 2005 | 1741 | 0.150 |
Why?
|
Positive-Pressure Respiration | 1 | 2021 | 632 | 0.150 |
Why?
|
Laryngeal Diseases | 1 | 2020 | 241 | 0.150 |
Why?
|
Facial Nerve | 1 | 2019 | 271 | 0.150 |
Why?
|
Reoperation | 6 | 2018 | 4203 | 0.150 |
Why?
|
Laryngoplasty | 1 | 2017 | 53 | 0.150 |
Why?
|
Carcinoma, Adenoid Cystic | 1 | 2019 | 252 | 0.150 |
Why?
|
Radiation Injuries | 2 | 2018 | 1178 | 0.150 |
Why?
|
Hirudins | 1 | 2018 | 183 | 0.150 |
Why?
|
Perception | 1 | 2023 | 1198 | 0.140 |
Why?
|
Disease Management | 2 | 2019 | 2458 | 0.140 |
Why?
|
Clavicle | 1 | 2018 | 209 | 0.140 |
Why?
|
Thailand | 1 | 2017 | 296 | 0.140 |
Why?
|
Immunohistochemistry | 8 | 2019 | 11368 | 0.140 |
Why?
|
Neoplasms, Unknown Primary | 2 | 2016 | 104 | 0.140 |
Why?
|
Equipment Design | 2 | 2017 | 3582 | 0.140 |
Why?
|
North America | 2 | 2017 | 1250 | 0.140 |
Why?
|
Survival Analysis | 6 | 2016 | 10250 | 0.140 |
Why?
|
Accessory Nerve | 1 | 2015 | 11 | 0.140 |
Why?
|
Cohort Studies | 9 | 2024 | 40559 | 0.130 |
Why?
|
Forearm | 2 | 2023 | 409 | 0.130 |
Why?
|
Credentialing | 1 | 2016 | 126 | 0.130 |
Why?
|
Republic of Korea | 1 | 2017 | 539 | 0.130 |
Why?
|
Case-Control Studies | 6 | 2023 | 21752 | 0.130 |
Why?
|
Hospitals, University | 1 | 2017 | 571 | 0.130 |
Why?
|
Speech Intelligibility | 1 | 2015 | 81 | 0.130 |
Why?
|
Ultrasonography, Doppler | 1 | 2017 | 458 | 0.130 |
Why?
|
Swine | 3 | 2015 | 5940 | 0.130 |
Why?
|
Chickens | 1 | 2017 | 865 | 0.130 |
Why?
|
DNA, Neoplasm | 3 | 2015 | 1758 | 0.130 |
Why?
|
Intubation, Gastrointestinal | 1 | 2016 | 152 | 0.130 |
Why?
|
Axilla | 1 | 2017 | 595 | 0.130 |
Why?
|
SEER Program | 3 | 2020 | 1508 | 0.130 |
Why?
|
Learning Curve | 2 | 2018 | 208 | 0.130 |
Why?
|
Incidence | 7 | 2019 | 20945 | 0.120 |
Why?
|
Surgical Wound Dehiscence | 1 | 2015 | 215 | 0.120 |
Why?
|
Video-Assisted Surgery | 1 | 2014 | 51 | 0.120 |
Why?
|
Periosteum | 1 | 2015 | 138 | 0.120 |
Why?
|
Positron-Emission Tomography | 3 | 2016 | 6274 | 0.120 |
Why?
|
Surgical Instruments | 1 | 2017 | 395 | 0.120 |
Why?
|
Time Factors | 7 | 2021 | 40063 | 0.120 |
Why?
|
Phosphodiesterase 5 Inhibitors | 1 | 2015 | 101 | 0.120 |
Why?
|
Models, Anatomic | 2 | 2015 | 690 | 0.120 |
Why?
|
Adenocarcinoma, Follicular | 1 | 2017 | 324 | 0.120 |
Why?
|
Microvessels | 1 | 2018 | 544 | 0.120 |
Why?
|
Neoplasms, Nerve Tissue | 1 | 2013 | 23 | 0.110 |
Why?
|
HSP70 Heat-Shock Proteins | 1 | 1995 | 404 | 0.110 |
Why?
|
Finite Element Analysis | 1 | 2015 | 431 | 0.110 |
Why?
|
Adenoma, Pleomorphic | 1 | 2014 | 75 | 0.110 |
Why?
|
Adenoma | 1 | 2004 | 2174 | 0.110 |
Why?
|
Multivariate Analysis | 4 | 2017 | 12244 | 0.110 |
Why?
|
Young Adult | 9 | 2021 | 56436 | 0.110 |
Why?
|
Adolescent | 9 | 2017 | 85759 | 0.110 |
Why?
|
Carbolines | 1 | 2015 | 265 | 0.110 |
Why?
|
Esthetics | 1 | 2014 | 306 | 0.110 |
Why?
|
Glycosaminoglycans | 2 | 2006 | 624 | 0.110 |
Why?
|
Salivation | 1 | 2012 | 22 | 0.110 |
Why?
|
Hashimoto Disease | 1 | 2013 | 97 | 0.110 |
Why?
|
Fluorodeoxyglucose F18 | 3 | 2019 | 2017 | 0.110 |
Why?
|
Analysis of Variance | 3 | 2011 | 6367 | 0.110 |
Why?
|
Treatment Failure | 1 | 2018 | 2619 | 0.110 |
Why?
|
Salivary Gland Neoplasms | 1 | 2016 | 298 | 0.110 |
Why?
|
Chemotherapy, Adjuvant | 1 | 2020 | 3474 | 0.100 |
Why?
|
Skull Base Neoplasms | 1 | 2016 | 284 | 0.100 |
Why?
|
Dehydration | 1 | 2013 | 234 | 0.100 |
Why?
|
Rhabdomyosarcoma, Alveolar | 1 | 2011 | 41 | 0.100 |
Why?
|
Time and Motion Studies | 1 | 2011 | 149 | 0.100 |
Why?
|
Follow-Up Studies | 7 | 2014 | 39045 | 0.100 |
Why?
|
Baltimore | 1 | 2011 | 231 | 0.100 |
Why?
|
Saliva | 1 | 2015 | 809 | 0.100 |
Why?
|
In Situ Hybridization | 4 | 2016 | 1950 | 0.100 |
Why?
|
Rhabdomyosarcoma, Embryonal | 1 | 2011 | 102 | 0.090 |
Why?
|
Internet | 1 | 2023 | 3063 | 0.090 |
Why?
|
Surgical Staplers | 1 | 2010 | 34 | 0.090 |
Why?
|
Stress, Mechanical | 1 | 2015 | 1686 | 0.090 |
Why?
|
Thyroid Nodule | 1 | 2017 | 750 | 0.090 |
Why?
|
Radial Artery | 1 | 2011 | 194 | 0.090 |
Why?
|
Human papillomavirus 11 | 1 | 2009 | 14 | 0.090 |
Why?
|
Postoperative Hemorrhage | 1 | 2013 | 412 | 0.090 |
Why?
|
Risk Factors | 9 | 2022 | 72280 | 0.090 |
Why?
|
Quality Assurance, Health Care | 1 | 2020 | 2211 | 0.090 |
Why?
|
Respiratory Tract Neoplasms | 1 | 2009 | 57 | 0.090 |
Why?
|
Phantoms, Imaging | 2 | 2015 | 2480 | 0.090 |
Why?
|
Proportional Hazards Models | 5 | 2017 | 12355 | 0.090 |
Why?
|
Aorta, Thoracic | 1 | 2015 | 1082 | 0.090 |
Why?
|
Negative-Pressure Wound Therapy | 1 | 2011 | 150 | 0.080 |
Why?
|
Ultrasonography, Interventional | 1 | 2017 | 1483 | 0.080 |
Why?
|
Practice Guidelines as Topic | 2 | 2016 | 7281 | 0.080 |
Why?
|
Intraoperative Period | 1 | 2010 | 520 | 0.080 |
Why?
|
Stroboscopy | 1 | 2009 | 64 | 0.080 |
Why?
|
Disability Evaluation | 1 | 2016 | 1828 | 0.080 |
Why?
|
Radiotherapy | 2 | 2021 | 1525 | 0.080 |
Why?
|
Patient Satisfaction | 1 | 2021 | 3395 | 0.080 |
Why?
|
Bone Transplantation | 1 | 2013 | 907 | 0.080 |
Why?
|
Cysts | 1 | 2014 | 679 | 0.080 |
Why?
|
Immunity, Cellular | 1 | 2015 | 1607 | 0.080 |
Why?
|
Papilloma | 1 | 2009 | 148 | 0.080 |
Why?
|
Linear Models | 2 | 2020 | 5953 | 0.080 |
Why?
|
Carcinoma, Papillary | 1 | 2013 | 783 | 0.080 |
Why?
|
Regression Analysis | 2 | 2017 | 6461 | 0.080 |
Why?
|
Recombinant Proteins | 1 | 2018 | 6612 | 0.080 |
Why?
|
Radiopharmaceuticals | 2 | 2016 | 2662 | 0.080 |
Why?
|
Voice Quality | 1 | 2009 | 217 | 0.080 |
Why?
|
Soft Tissue Injuries | 1 | 2009 | 176 | 0.080 |
Why?
|
Pain Measurement | 1 | 2017 | 3419 | 0.070 |
Why?
|
Immunoglobulin G | 2 | 1998 | 4559 | 0.070 |
Why?
|
Endopeptidase K | 1 | 2006 | 23 | 0.070 |
Why?
|
Tomography, X-Ray Computed | 5 | 2016 | 20123 | 0.070 |
Why?
|
Sarcoma | 1 | 2018 | 1897 | 0.070 |
Why?
|
Intensive Care Units | 2 | 2017 | 3680 | 0.070 |
Why?
|
Osmotic Pressure | 2 | 1998 | 151 | 0.070 |
Why?
|
Ambulatory Surgical Procedures | 1 | 2011 | 454 | 0.070 |
Why?
|
Postoperative Period | 3 | 2018 | 1841 | 0.070 |
Why?
|
Ultrasonography | 2 | 2017 | 5982 | 0.070 |
Why?
|
Voice Disorders | 1 | 2009 | 276 | 0.070 |
Why?
|
Program Development | 1 | 2012 | 1315 | 0.070 |
Why?
|
Education, Medical, Graduate | 1 | 2018 | 2291 | 0.070 |
Why?
|
Compressive Strength | 1 | 2006 | 169 | 0.070 |
Why?
|
Tissue Engineering | 2 | 2006 | 1880 | 0.070 |
Why?
|
Antibodies, Viral | 1 | 2017 | 3176 | 0.070 |
Why?
|
Survivors | 1 | 2016 | 2291 | 0.070 |
Why?
|
Guideline Adherence | 1 | 2016 | 2266 | 0.070 |
Why?
|
Predictive Value of Tests | 6 | 2019 | 15070 | 0.060 |
Why?
|
Hydrolysis | 1 | 2006 | 682 | 0.060 |
Why?
|
Graft Rejection | 2 | 2018 | 4399 | 0.060 |
Why?
|
Logistic Models | 3 | 2016 | 13409 | 0.060 |
Why?
|
Animals | 8 | 2017 | 168788 | 0.060 |
Why?
|
Carotid Arteries | 1 | 2009 | 952 | 0.060 |
Why?
|
Tensile Strength | 1 | 2005 | 335 | 0.060 |
Why?
|
Pilot Projects | 3 | 2023 | 8321 | 0.060 |
Why?
|
Cell Membrane Permeability | 1 | 2006 | 590 | 0.060 |
Why?
|
Evidence-Based Medicine | 1 | 2016 | 3611 | 0.060 |
Why?
|
Voice | 1 | 2007 | 259 | 0.060 |
Why?
|
Tumor Suppressor Protein p53 | 1 | 2014 | 2948 | 0.060 |
Why?
|
Radiation Dosage | 1 | 2012 | 1928 | 0.060 |
Why?
|
Probability | 1 | 2009 | 2505 | 0.060 |
Why?
|
Bone Morphogenetic Protein 2 | 1 | 2005 | 350 | 0.060 |
Why?
|
Skin Neoplasms | 1 | 2023 | 5670 | 0.060 |
Why?
|
Biopsy | 2 | 2014 | 6757 | 0.060 |
Why?
|
Clinical Trials as Topic | 1 | 2019 | 7908 | 0.060 |
Why?
|
Fibroblast Growth Factor 2 | 1 | 2005 | 599 | 0.060 |
Why?
|
Patient Readmission | 2 | 2016 | 3114 | 0.060 |
Why?
|
Anisotropy | 1 | 2006 | 1265 | 0.050 |
Why?
|
Chi-Square Distribution | 1 | 2009 | 3509 | 0.050 |
Why?
|
Cyclin-Dependent Kinase Inhibitor p16 | 2 | 2017 | 704 | 0.050 |
Why?
|
Antisepsis | 1 | 2022 | 18 | 0.050 |
Why?
|
Melanoma | 1 | 2021 | 5475 | 0.050 |
Why?
|
Comorbidity | 2 | 2014 | 10387 | 0.050 |
Why?
|
High-Throughput Nucleotide Sequencing | 1 | 2015 | 3598 | 0.050 |
Why?
|
Dilatation | 1 | 2023 | 291 | 0.050 |
Why?
|
Physicians | 1 | 2020 | 4564 | 0.050 |
Why?
|
Health Care Surveys | 1 | 2009 | 2453 | 0.050 |
Why?
|
Sensation | 1 | 2023 | 337 | 0.050 |
Why?
|
Embolization, Therapeutic | 2 | 2009 | 1392 | 0.050 |
Why?
|
Transforming Growth Factor beta1 | 1 | 2005 | 644 | 0.050 |
Why?
|
DNA Methylation | 1 | 2015 | 4289 | 0.050 |
Why?
|
Neuroglia | 2 | 1996 | 927 | 0.050 |
Why?
|
Oropharynx | 1 | 2021 | 127 | 0.050 |
Why?
|
Enzyme Induction | 2 | 1998 | 475 | 0.050 |
Why?
|
Bone Morphogenetic Proteins | 1 | 2005 | 838 | 0.050 |
Why?
|
Databases, Factual | 2 | 2014 | 7730 | 0.040 |
Why?
|
Radius | 1 | 2023 | 422 | 0.040 |
Why?
|
Health Care Costs | 1 | 2013 | 3209 | 0.040 |
Why?
|
Constriction, Pathologic | 1 | 2023 | 1107 | 0.040 |
Why?
|
Temperature | 1 | 2006 | 2206 | 0.040 |
Why?
|
Sex Distribution | 2 | 2016 | 2297 | 0.040 |
Why?
|
Sural Nerve | 1 | 2019 | 112 | 0.040 |
Why?
|
Palate, Soft | 1 | 2019 | 96 | 0.040 |
Why?
|
Survival Rate | 3 | 2021 | 12781 | 0.040 |
Why?
|
Cell Transformation, Neoplastic | 1 | 2009 | 2942 | 0.040 |
Why?
|
Age Distribution | 2 | 2016 | 2903 | 0.040 |
Why?
|
Computer Simulation | 1 | 2012 | 6196 | 0.040 |
Why?
|
Gene Expression Profiling | 1 | 2015 | 9438 | 0.040 |
Why?
|
Genetic Predisposition to Disease | 3 | 2015 | 17449 | 0.040 |
Why?
|
Electronic Health Records | 1 | 2015 | 4463 | 0.040 |
Why?
|
Prolapse | 1 | 2017 | 68 | 0.040 |
Why?
|
Collagen | 1 | 2006 | 2689 | 0.040 |
Why?
|
Nerve Transfer | 1 | 2019 | 120 | 0.040 |
Why?
|
Child | 5 | 2017 | 77679 | 0.040 |
Why?
|
Transforming Growth Factor beta | 1 | 2005 | 2008 | 0.040 |
Why?
|
Insulin-Like Growth Factor I | 1 | 2005 | 2014 | 0.040 |
Why?
|
Sex Factors | 3 | 2017 | 10396 | 0.040 |
Why?
|
Rats, Sprague-Dawley | 3 | 1998 | 8302 | 0.040 |
Why?
|
Software | 1 | 2011 | 4442 | 0.040 |
Why?
|
Papillomavirus E7 Proteins | 1 | 2017 | 123 | 0.040 |
Why?
|
Fluorescent Antibody Technique | 2 | 1998 | 2505 | 0.030 |
Why?
|
Mutation | 3 | 2015 | 29784 | 0.030 |
Why?
|
Image Processing, Computer-Assisted | 1 | 2013 | 8950 | 0.030 |
Why?
|
Kaplan-Meier Estimate | 2 | 2017 | 6535 | 0.030 |
Why?
|
Attitude of Health Personnel | 1 | 2009 | 3842 | 0.030 |
Why?
|
Heme Oxygenase-1 | 1 | 1998 | 381 | 0.030 |
Why?
|
Fixatives | 1 | 2015 | 94 | 0.030 |
Why?
|
Age Factors | 3 | 2020 | 18367 | 0.030 |
Why?
|
Mannitol | 1 | 1995 | 181 | 0.030 |
Why?
|
Oncogene Proteins, Viral | 1 | 2017 | 362 | 0.030 |
Why?
|
Cyclic Nucleotide Phosphodiesterases, Type 5 | 1 | 2015 | 34 | 0.030 |
Why?
|
Cyclohexanecarboxylic Acids | 1 | 2016 | 143 | 0.030 |
Why?
|
Epithelial-Mesenchymal Transition | 1 | 2019 | 713 | 0.030 |
Why?
|
Hospitalization | 1 | 2014 | 10262 | 0.030 |
Why?
|
Immunoblotting | 1 | 1998 | 1682 | 0.030 |
Why?
|
Gastroscopy | 1 | 2016 | 207 | 0.030 |
Why?
|
Amines | 1 | 2016 | 278 | 0.030 |
Why?
|
Therapeutic Irrigation | 1 | 2015 | 301 | 0.030 |
Why?
|
Kinetics | 1 | 2022 | 6474 | 0.030 |
Why?
|
Cleft Palate | 1 | 2019 | 560 | 0.030 |
Why?
|
Paraffin Embedding | 1 | 2015 | 299 | 0.030 |
Why?
|
Quality of Health Care | 1 | 2009 | 4371 | 0.030 |
Why?
|
Tissue Fixation | 1 | 2015 | 241 | 0.030 |
Why?
|
Disease Models, Animal | 1 | 2012 | 18027 | 0.030 |
Why?
|
Formaldehyde | 1 | 2015 | 353 | 0.030 |
Why?
|
Drinking | 1 | 2014 | 197 | 0.030 |
Why?
|
Ear Auricle | 1 | 2012 | 32 | 0.030 |
Why?
|
Radiotherapy, Conformal | 1 | 2016 | 548 | 0.030 |
Why?
|
Esophagectomy | 1 | 2016 | 447 | 0.030 |
Why?
|
Immunoenzyme Techniques | 1 | 1995 | 1799 | 0.030 |
Why?
|
Confidence Intervals | 1 | 2018 | 2970 | 0.030 |
Why?
|
Radiotherapy, High-Energy | 1 | 2012 | 228 | 0.030 |
Why?
|
Hemostasis, Surgical | 1 | 2012 | 128 | 0.030 |
Why?
|
Needs Assessment | 1 | 2018 | 1147 | 0.030 |
Why?
|
Consensus | 1 | 2021 | 2958 | 0.030 |
Why?
|
Rats | 3 | 1998 | 24273 | 0.030 |
Why?
|
Bronchoscopy | 1 | 2017 | 862 | 0.030 |
Why?
|
Seroma | 1 | 2011 | 71 | 0.020 |
Why?
|
Osteoradionecrosis | 1 | 2011 | 49 | 0.020 |
Why?
|
Metagenome | 1 | 2014 | 418 | 0.020 |
Why?
|
Neoplasm, Residual | 1 | 2015 | 972 | 0.020 |
Why?
|
Hypocalcemia | 1 | 2011 | 191 | 0.020 |
Why?
|
gamma-Aminobutyric Acid | 1 | 2016 | 1123 | 0.020 |
Why?
|
Cells, Cultured | 1 | 2005 | 19227 | 0.020 |
Why?
|
Preoperative Period | 1 | 2011 | 548 | 0.020 |
Why?
|
Biopsy, Fine-Needle | 1 | 2014 | 1094 | 0.020 |
Why?
|
Thigh | 1 | 2010 | 247 | 0.020 |
Why?
|
Child, Preschool | 1 | 2011 | 40992 | 0.020 |
Why?
|
Analgesics | 1 | 2016 | 1040 | 0.020 |
Why?
|
DNA | 1 | 2023 | 7303 | 0.020 |
Why?
|
Reproducibility of Results | 2 | 2017 | 19907 | 0.020 |
Why?
|
User-Computer Interface | 1 | 2015 | 1426 | 0.020 |
Why?
|
Prevalence | 2 | 2016 | 15226 | 0.020 |
Why?
|
Vocal Cord Paralysis | 1 | 2011 | 267 | 0.020 |
Why?
|
Databases, Genetic | 1 | 2015 | 1782 | 0.020 |
Why?
|
Activities of Daily Living | 1 | 2017 | 2420 | 0.020 |
Why?
|
Smoking | 2 | 2014 | 8986 | 0.020 |
Why?
|
Vocal Cords | 1 | 2011 | 528 | 0.020 |
Why?
|
Face | 1 | 2012 | 994 | 0.020 |
Why?
|
Hematoma | 1 | 2011 | 758 | 0.020 |
Why?
|
DNA Copy Number Variations | 1 | 2015 | 1940 | 0.020 |
Why?
|
Disease Progression | 2 | 2015 | 13280 | 0.020 |
Why?
|
Repressor Proteins | 1 | 2017 | 3023 | 0.020 |
Why?
|
Genetic Association Studies | 1 | 2015 | 2702 | 0.020 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 1 | 2013 | 4752 | 0.020 |
Why?
|
Radiology | 1 | 2019 | 2099 | 0.020 |
Why?
|
Brain Injuries | 1 | 1996 | 2025 | 0.020 |
Why?
|
Prosthesis Design | 1 | 2011 | 2110 | 0.020 |
Why?
|
Neoplasm Metastasis | 1 | 2015 | 4841 | 0.020 |
Why?
|
Critical Care | 1 | 2017 | 2644 | 0.020 |
Why?
|
Interferon-gamma | 1 | 2013 | 3203 | 0.010 |
Why?
|
Prosthesis Failure | 1 | 2009 | 1206 | 0.010 |
Why?
|
Blood Pressure | 2 | 1996 | 8551 | 0.010 |
Why?
|
Anti-Bacterial Agents | 1 | 2021 | 7179 | 0.010 |
Why?
|
Gene Expression | 1 | 1995 | 7799 | 0.010 |
Why?
|
Flow Cytometry | 1 | 2013 | 5974 | 0.010 |
Why?
|
Fees, Medical | 1 | 2002 | 117 | 0.010 |
Why?
|
Ligation | 1 | 2002 | 453 | 0.010 |
Why?
|
Wound Healing | 1 | 2011 | 2785 | 0.010 |
Why?
|
Contrast Media | 1 | 2012 | 5300 | 0.010 |
Why?
|
CD8-Positive T-Lymphocytes | 1 | 2013 | 4477 | 0.010 |
Why?
|
RNA, Messenger | 1 | 2014 | 13036 | 0.010 |
Why?
|
Antibodies, Monoclonal | 1 | 1995 | 9275 | 0.010 |
Why?
|
Genomics | 1 | 2014 | 5722 | 0.010 |
Why?
|
Calcium | 1 | 2011 | 5757 | 0.010 |
Why?
|
Phenotype | 1 | 2015 | 16365 | 0.010 |
Why?
|
T-Lymphocytes | 1 | 2015 | 10182 | 0.010 |
Why?
|
Costs and Cost Analysis | 1 | 2002 | 1682 | 0.010 |
Why?
|
Neurons | 1 | 1995 | 9335 | 0.010 |
Why?
|
Glial Fibrillary Acidic Protein | 1 | 1996 | 528 | 0.010 |
Why?
|
Diagnosis, Differential | 1 | 2009 | 12961 | 0.010 |
Why?
|
Oligodendroglia | 1 | 1996 | 519 | 0.010 |
Why?
|
Algorithms | 1 | 2013 | 13885 | 0.010 |
Why?
|
Brain | 1 | 1996 | 26413 | 0.010 |
Why?
|
Cerebellum | 1 | 1996 | 1490 | 0.010 |
Why?
|
Astrocytes | 1 | 1996 | 1270 | 0.010 |
Why?
|
Microglia | 1 | 1996 | 1266 | 0.000 |
Why?
|
Cerebral Cortex | 1 | 1996 | 5709 | 0.000 |
Why?
|